Loading organizations...
Loading organizations...
Drug discovery company developing therapies for inflammatory conditions.
Tay Therapeutics has raised $2.2M across 1 funding round.
Tay Therapeutics has raised $2.2M in total across 1 funding round.
Tay Therapeutics has raised $2.2M in total across 1 funding round.
Tay Therapeutics's investors include Sunil Shah, Meltwind, Kerry Sharp, Anne Muir, Wren Capital.
Tay Therapeutics has raised $2.2M across 1 funding round. Most recently, it raised $2.2M Pre-Series A in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 2, 2021 | $2.2M Pre-Series A | Sunil Shah | Meltwind, Kerry Sharp, Anne Muir, Wren Capital |